Louis De Muynck
Janssen R&D
Beerse, VLG, Belgium
Beerse, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Dysregulation of complement at the synapse in P301S mice and human tauopathies.
Journal: Acta neuropathologica communications
Published: December 12, 2025
In vivo validation of novel non-invasive PHP.eB AAVs as a potential therapeutic approach for alpha-synucleinopathies.
Journal: Acta neuropathologica communications
Published: May 27, 2025
Complement dysregulation in human tauopathies.
Journal: Brain pathology (Zurich, Switzerland)
Published: May 03, 2025
Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants.
Journal: Molecular neurodegeneration
Published: June 09, 2023
The 3-O sulfation of heparan sulfate proteoglycans contributes to the cellular internalization of tau aggregates.
Journal: BMC molecular and cell biology
Published: July 13, 2022
Differentially expressed genes in Alzheimer's disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1.
Journal: Brain, behavior, & immunity - health
Published: December 16, 2020
Absence of Uptake and Prion-Like Spreading of Alpha-Synuclein and Tau After Intravitreal Injection of Preformed Fibrils.
Journal: Frontiers in aging neuroscience
Published: October 06, 2020
PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding.
Journal: The Journal of biological chemistry
Published: September 29, 2020
Genetically Engineered iPSC-Derived FTDP-17 MAPT Neurons Display Mutation-Specific Neurodegenerative and Neurodevelopmental Phenotypes.
Journal: Stem cell reports
Published: August 15, 2019
Genetically Engineered iPSC-Derived FTDP-17 MAPT Neurons Display Mutation-Specific Neurodegenerative and Neurodevelopmental Phenotypes.
Journal: Stem cell reports
Published: September 30, 2017
Last Updated: 09/26/2026